- Home
- TXG vs QQQX Comparison
TXG vs QQQX Comparison
Compare TXG & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXG
- QQQX
- Stock Information
- Founded
- TXG 2012
- QQQX 2007
- Country
- TXG United States
- QQQX United States
- Employees
- TXG N/A
- QQQX N/A
- Industry
- TXG Biotechnology: Laboratory Analytical Instruments
- QQQX Finance Companies
- Sector
- TXG Industrials
- QQQX Finance
- Exchange
- TXG Nasdaq
- QQQX Nasdaq
- Market Cap
- TXG 1.0B
- QQQX 1.1B
- IPO Year
- TXG 2019
- QQQX N/A
- Fundamental
- Price
- TXG $8.63
- QQQX $24.30
- Analyst Decision
- TXG Buy
- QQQX
- Analyst Count
- TXG 15
- QQQX 0
- Target Price
- TXG $18.85
- QQQX N/A
- AVG Volume (30 Days)
- TXG 3.9M
- QQQX 127.6K
- Earning Date
- TXG 05-08-2025
- QQQX 01-01-0001
- Dividend Yield
- TXG N/A
- QQQX 7.03%
- EPS Growth
- TXG N/A
- QQQX N/A
- EPS
- TXG N/A
- QQQX N/A
- Revenue
- TXG $610,785,000.00
- QQQX N/A
- Revenue This Year
- TXG $0.71
- QQQX N/A
- Revenue Next Year
- TXG $9.28
- QQQX N/A
- P/E Ratio
- TXG N/A
- QQQX N/A
- Revenue Growth
- TXG N/A
- QQQX N/A
- 52 Week Low
- TXG $6.78
- QQQX $20.27
- 52 Week High
- TXG $28.25
- QQQX $25.99
- Technical
- Relative Strength Index (RSI)
- TXG 51.19
- QQQX 57.93
- Support Level
- TXG $7.72
- QQQX $23.90
- Resistance Level
- TXG $8.63
- QQQX $24.51
- Average True Range (ATR)
- TXG 0.43
- QQQX 0.39
- MACD
- TXG 0.14
- QQQX 0.19
- Stochastic Oscillator
- TXG 84.92
- QQQX 92.71
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek an attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.